Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Tag: clinical phase 1 trial

IgGenix Doses Final Participant in Phase 1 Study of Novel Peanut...

Toothpaste Treatment for Peanut Allergy Passes First Hurdle

New Peanut Allergy Vaccine Shows Promise in Phase 1 Trial

IgGenix Demonstrates the Potential of Targeted Therapeutic for Peanut Allergy Ahead...

Needle-Free Powder Epinephrine Nasal Spray Shows Positive Results in Clinical Study

Intrommune’s Peanut Allergy Toothpaste Therapy Reaches Phase 1 Clinical Trial Milestone

Company Announces First Patient Dosing with Peanut Allergy Vaccine

ALK Starts Clinical Trial of SLIT Tablet to Treat Peanut Allergy

Peanut Allergy Immunotherapy Toothpaste Makes Strides Toward Phase 2 Trial

Aquestive’s Sublingual Epinephrine Achieves Therapeutic Blood Concentrations Following Administration

Your School On Our Map

Put Your School on the Map